Gil M. Labrucherie, SVP & Chief Financial Officer at NEKTAR THERAPEUTICS (NKTR), sold 25,000 shares at $20.52 ($513K) on 2019-09-16, disclosed to the SEC on 2019-09-18.
Open-market sale of $513k NKTR by SVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |